These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9614197)

  • 1. Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors.
    Virginio C; Robertson G; Surprenant A; North RA
    Mol Pharmacol; 1998 Jun; 53(6):969-73. PubMed ID: 9614197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of cloned P2X receptors.
    North RA; Surprenant A
    Annu Rev Pharmacol Toxicol; 2000; 40():563-80. PubMed ID: 10836147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular physiology of P2X receptors.
    North RA
    Physiol Rev; 2002 Oct; 82(4):1013-67. PubMed ID: 12270951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.
    Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C
    J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Go it alone no more--P2X7 joins the society of heteromeric ATP-gated receptor channels.
    Dubyak GR
    Mol Pharmacol; 2007 Dec; 72(6):1402-5. PubMed ID: 17895406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices.
    Papp L; Balázsa T; Köfalvi A; Erdélyi F; Szabó G; Vizi ES; Sperlágh B
    J Pharmacol Exp Ther; 2004 Sep; 310(3):973-80. PubMed ID: 15084650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes.
    Aschrafi A; Sadtler S; Niculescu C; Rettinger J; Schmalzing G
    J Mol Biol; 2004 Sep; 342(1):333-43. PubMed ID: 15313628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor.
    Wilkinson WJ; Jiang LH; Surprenant A; North RA
    Mol Pharmacol; 2006 Oct; 70(4):1159-63. PubMed ID: 16840712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory interdependence of cloned epithelial Na+ channels and P2X receptors.
    Wildman SS; Marks J; Churchill LJ; Peppiatt CM; Chraibi A; Shirley DG; Horisberger JD; King BF; Unwin RJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2586-97. PubMed ID: 16000699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
    Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits.
    Nicke A; Kerschensteiner D; Soto F
    J Neurochem; 2005 Feb; 92(4):925-33. PubMed ID: 15686495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.
    Spelta V; Jiang LH; Surprenant A; North RA
    Br J Pharmacol; 2002 Mar; 135(6):1524-30. PubMed ID: 11906966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Ca2+ influx through recombinant P2X receptor in C6BU-1 cells.
    Ueno S; Koizumi S; Inoue K
    Br J Pharmacol; 1998 Aug; 124(7):1484-90. PubMed ID: 9723962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones.
    Thomas S; Virginio C; North RA; Surprenant A
    J Physiol; 1998 Jun; 509 ( Pt 2)(Pt 2):411-7. PubMed ID: 9575290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor.
    King BF; Wildman SS; Ziganshina LE; Pintor J; Burnstock G
    Br J Pharmacol; 1997 Aug; 121(7):1445-53. PubMed ID: 9257926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel.
    Torres GE; Haines WR; Egan TM; Voigt MM
    Mol Pharmacol; 1998 Dec; 54(6):989-93. PubMed ID: 9855626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
    Rettinger J; Braun K; Hochmann H; Kassack MU; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Neuropharmacology; 2005 Mar; 48(3):461-8. PubMed ID: 15721178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in expression of P2X purinoceptors in rat cerebellum during postnatal development.
    Xiang Z; Burnstock G
    Brain Res Dev Brain Res; 2005 May; 156(2):147-57. PubMed ID: 16099301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.
    Neelands TR; Burgard EC; Uchic ME; McDonald HA; Niforatos W; Faltynek CR; Lynch KJ; Jarvis MF
    Br J Pharmacol; 2003 Sep; 140(1):202-10. PubMed ID: 12967950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.